FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
FURX was delisted on the 1st of July, 2014.
114 hedge funds and large institutions have $565M invested in FURIEX PHARMACEUTICALS INC COM STK (DE) in 2014 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 26 increasing their positions, 39 reducing their positions, and 7 closing their positions.
457% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 7
116% more capital invested
Capital invested by funds: $261M → $565M (+$304M)
61% more call options, than puts
Call options by funds: $42M | Put options by funds: $26M
36% more funds holding
Funds holding: 84 → 114 (+30)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
33% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 39
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$24.6M |
| 2 |
PC
PointState Capital
New York
|
+$20.8M |
| 3 |
Morgan Stanley
New York
|
+$13.3M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$11.6M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$9.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$21.6M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$20.4M |
| 3 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
-$18.2M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$8.78M |
| 5 |
Jennison Associates
New York
|
-$7.12M |
FURX Hedge Fund Activity: Q1 2014 in Review
114 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) for Q1 2014, worth a combined $565M — up 116% from $261M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new FURX positions and 7 closed out — a net gain of 32 holders — while 26 added to existing stakes and 39 trimmed.
The largest buyer was Millennium Management, adding an estimated $24.6M. The largest seller was Visium Asset Management, cutting an estimated $21.6M.
- 114 institutional investors held FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) as of Q1 2014, up from 84 in Q4 2013.
- Funds reported $565M of FURIEX PHARMACEUTICALS INC COM STK (DE) stock for Q1 2014, up 116% quarter-over-quarter.
- 39 funds opened new FURIEX PHARMACEUTICALS INC COM STK (DE) positions in Q1 2014 and 7 closed out, a net change of +32 holders.
- The largest FURIEX PHARMACEUTICALS INC COM STK (DE) buyer in Q1 2014 was Millennium Management, an estimated $24.6M added.
- The largest FURIEX PHARMACEUTICALS INC COM STK (DE) seller in Q1 2014 was Visium Asset Management, an estimated $21.6M sold.
Based on aggregated 13F filings for Q1 2014.